Literature DB >> 11169771

Mechanisms of adenosine 5'-triphosphate-induced dopamine release in the rat nucleus accumbens in vivo.

U Krügel1, H Kittner, P Illes.   

Abstract

The endogenous mechanisms modulating ATP-induced dopamine release in the nucleus accumbens (NAc) were studied by microdialysis in freely moving rats. The ATP analog 2-Methylthio ATP (2-MeSATP) facilitated the release of dopamine in a manner sensitive to pertussis toxin and tetrodotoxin. It is suggested that G-protein-coupled P2Y receptors and voltage-gated sodium channels are involved in this process. N-methyl-D-aspartate (NMDA) applied in a concentration of 100 microM decreased the extracellular dopamine level, whereas 1 and 10 mM NMDA enhanced it. The endogenous agonist glutamate (10 microM) inhibited the basal and facilitated release of dopamine. Infusion with a combination of the ionotropic glutamate receptor antagonists (+/-)-3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP) and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), as well as with the metabotropic glutamate receptor antagonist (+/-)-alpha-methyl-4-carboxyphenylglycine (MCPG) increased the basal level of dopamine and potentiated the 2-MeSATP-facilitated dopamine release, suggesting an ATP-mediated glutamate release. The GABA(A) receptor antagonist bicuculline infused into the NAc also enhanced the basal level of dopamine; however, the application of 2-MeSATP in the presence of bicuculline caused an early decrease and a subsequent increase of dopamine release. The facilitatory phase of the 2-MeSATP effect was comparable with that measured in the absence of bicuculline. By contrast, when bicuculline was infused into the ventral tegmental area (VTA) it elevated the accumbal basal dopamine level and in addition facilitated the 2-MeSATP- and the glutamate-induced dopamine release above that measured in the absence of bicuculline. These results suggest that ATP in the NAc has a physiologically relevant function in modulating dopaminergic transmission depending on the mesolimbic neuronal activity. The first component of the ATP effect involves a direct stimulation of the terminals of VTA neurons, while the second inhibitory component involves a sequential activation of glutamate and, finally, via ionotropic and metabotropic glutamate receptors, of GABA neurons projecting to the VTA. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11169771     DOI: 10.1002/1098-2396(20010301)39:3<222::AID-SYN1003>3.0.CO;2-R

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  14 in total

Review 1.  Extracellular ATP and other nucleotides-ubiquitous triggers of intercellular messenger release.

Authors:  Herbert Zimmermann
Journal:  Purinergic Signal       Date:  2015-11-06       Impact factor: 3.765

2.  Impaired cognition after stimulation of P2Y1 receptors in the rat medial prefrontal cortex.

Authors:  Holger Koch; Anton Bespalov; Karla Drescher; Heike Franke; Ute Krügel
Journal:  Neuropsychopharmacology       Date:  2014-07-15       Impact factor: 7.853

3.  N-Acetyl cysteine reverses social isolation rearing induced changes in cortico-striatal monoamines in rats.

Authors:  Marisa Möller; Jan L Du Preez; Francois P Viljoen; Michael Berk; Brian H Harvey
Journal:  Metab Brain Dis       Date:  2013-09-03       Impact factor: 3.584

4.  Synthetic cathinone MDPV enhances reward function through purinergic P2X7 receptor-dependent pathway and increases P2X7 gene expression in nucleus accumbens.

Authors:  Taylor A Gentile; Steven J Simmons; Christopher S Tallarida; Shu Su; Slava Rom; Mia N Watson; Allen B Reitz; Raghava Potula; Scott M Rawls
Journal:  Drug Alcohol Depend       Date:  2019-01-31       Impact factor: 4.492

Review 5.  Pathophysiology of astroglial purinergic signalling.

Authors:  Heike Franke; Alexei Verkhratsky; Geoffrey Burnstock; Peter Illes
Journal:  Purinergic Signal       Date:  2012-05-01       Impact factor: 3.765

6.  P2Y receptor regulation of cultured rat cerebral cortical cells: calcium responses and mRNA expression in neurons and glia.

Authors:  Gillian C Bennett; Anthony P D W Ford; Jacqueline A M Smith; Caroline J Emmett; Tania E Webb; Michael R Boarder
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

Review 7.  P2Y receptors in Alzheimer's disease.

Authors:  Laurie Erb; Chen Cao; Deepa Ajit; Gary A Weisman
Journal:  Biol Cell       Date:  2014-10-13       Impact factor: 4.458

8.  Enhanced P2Y1 receptor expression in the brain after sensitisation with d-amphetamine.

Authors:  Heike Franke; Holger Kittner; Jens Grosche; Peter Illes
Journal:  Psychopharmacology (Berl)       Date:  2003-03-22       Impact factor: 4.530

9.  Reduced expression of purinergic P2X4 receptors increases voluntary ethanol intake in C57BL/6J mice.

Authors:  Sheraz Khoja; Nhat Huynh; Liana Asatryan; Michael W Jakowec; Daryl L Davies
Journal:  Alcohol       Date:  2017-09-30       Impact factor: 2.405

10.  Integration of P2Y receptor-activated signal transduction pathways in G protein-dependent signalling networks.

Authors:  Kristof Van Kolen; Herman Slegers
Journal:  Purinergic Signal       Date:  2006-06-07       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.